doi: 10.1016/S0140-6736(21)00782-0.
Epub 2021 Apr 9.
Correlates of protection from SARS-CoV-2 infection
Affiliations
- PMID: 33844964
- PMCID: PMC8040540
- DOI: 10.1016/S0140-6736(21)00782-0
Item in Clipboard
Correlates of protection from SARS-CoV-2 infection
Lancet.
.
No abstract available
Comment in
-
A New Normal Once Again.Pediatr Ann. 2021 Jul;50(7):e268-e269. doi: 10.3928/19382359-20210617-02. Epub 2021 Jul 1. Pediatr Ann. 2021. PMID: 34264795 No abstract available.
Dataset described in
-
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).Lancet. 2021 Apr 17;397(10283):1459-1469. doi: 10.1016/S0140-6736(21)00675-9. Epub 2021 Apr 9. Lancet. 2021. PMID: 33844963 Free PMC article.
Similar articles
-
Protective immunity after recovery from SARS-CoV-2 infection.Lancet Infect Dis. 2022 Jan;22(1):12-14. doi: 10.1016/S1473-3099(21)00676-9. Epub 2021 Nov 8. Lancet Infect Dis. 2022. PMID: 34762853 Free PMC article. No abstract available.
-
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.Emerg Microbes Infect. 2021 Dec;10(1):152-160. doi: 10.1080/22221751.2021.1872352. Emerg Microbes Infect. 2021. PMID: 33407005 Free PMC article.
-
SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.J Med Virol. 2021 Dec;93(12):6444-6446. doi: 10.1002/jmv.27200. Epub 2021 Jul 20. J Med Virol. 2021. PMID: 34260066 Free PMC article. No abstract available.
-
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.Nat Rev Immunol. 2021 Jun;21(6):395-404. doi: 10.1038/s41577-021-00550-x. Epub 2021 Apr 29. Nat Rev Immunol. 2021. PMID: 33927374 Free PMC article. Review.
-
Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.Int Immunopharmacol. 2021 Nov;100:108108. doi: 10.1016/j.intimp.2021.108108. Epub 2021 Sep 8. Int Immunopharmacol. 2021. PMID: 34521025 Free PMC article. Review.
Cited by
-
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers.Influenza Other Respir Viruses. 2022 Sep;16(5):916-925. doi: 10.1111/irv.12997. Epub 2022 May 5. Influenza Other Respir Viruses. 2022. PMID: 35510653 Free PMC article.
-
Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations.PLoS Pathog. 2022 Jun 30;18(6):e1010591. doi: 10.1371/journal.ppat.1010591. eCollection 2022 Jun. PLoS Pathog. 2022. PMID: 35771775 Free PMC article. Review.
-
SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.Microbiol Spectr. 2021 Oct 31;9(2):e0129821. doi: 10.1128/Spectrum.01298-21. Epub 2021 Oct 20. Microbiol Spectr. 2021. PMID: 34668728 Free PMC article.
-
Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19.Viruses. 2022 Feb 12;14(2):380. doi: 10.3390/v14020380. Viruses. 2022. PMID: 35215973 Free PMC article. Review.
-
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies.Cell Host Microbe. 2022 Aug 10;30(8):1103-1111.e6. doi: 10.1016/j.chom.2022.04.017. Epub 2022 May 6. Cell Host Microbe. 2022. PMID: 35588741 Free PMC article.
References
-
- Krammer F, Simon V. Serology assays to manage COVID-19. Science. 2020;368:1060–1061. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
